A potential protective role of magnesium in neuroCOVID.
- Published in:
- Magnesium Research, 2022, v. 35, n. 1, p. 18, doi. 10.1684/mrh.2022.0497
- By:
- Publication type:
- Article
Works by Cenacchi, Valentina
Results: 11
1
2
ADME properties of CHF6366, a novel bi-functional M3 muscarinic receptor antagonist and ß<sub>2</sub> adrenoceptor agonist (MABA) radiolabelled at both functional moieties.
- Published in:
- Xenobiotica, 2023, v. 53, n. 4, p. 288, doi. 10.1080/00498254.2023.2230490
- By:
- Publication type:
- Article
3
COVID-19 lockdown: Physical activity, sedentary behaviour and sleep in Italian medicine students.
- Published in:
- European Journal of Sport Science, 2021, v. 21, n. 10, p. 1459, doi. 10.1080/17461391.2020.1842910
- By:
- Publication type:
- Article
4
Co-ultraPEALut in Subjective Cognitive Impairment Following SARS-CoV-2 Infection: An Exploratory Retrospective Study.
- Published in:
- Brain Sciences (2076-3425), 2024, v. 14, n. 3, p. 293, doi. 10.3390/brainsci14030293
- By:
- Publication type:
- Article
5
From the Lab to Real Life: Monitoring Cardiorespiratory Fitness during the COVID-19 Pandemic through Wearable Devices. An Exploratory Longitudinal Study on Healthy Participants.
- Published in:
- Healthcare (2227-9032), 2022, v. 10, n. 4, p. 634, doi. 10.3390/healthcare10040634
- By:
- Publication type:
- Article
6
Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women.
- Published in:
- British Journal of Clinical Pharmacology, 2007, v. 64, n. 3, p. 304, doi. 10.1111/j.1365-2125.2007.02870.x
- By:
- Publication type:
- Article
7
In vitro and in vivo metabolism of CHF 6001, a selective phosphodiesterase (PDE4) inhibitor.
- Published in:
- Xenobiotica, 2015, v. 45, n. 8, p. 693, doi. 10.3109/00498254.2015.1014945
- By:
- Publication type:
- Article
8
P2-333: The gamma-secretase modulator CHF5074 acutely reduces brain Aβ42 in the guinea pig model of human β-amyloid production
- Published in:
- 2008
- By:
- Publication type:
- Abstract
9
P4-268: Pharmacokinetics and pharmacodynamics of CHF5022 and CHF5074, two new β-amyloid<sub>1-42</sub> lowering agents, after multiple doses in TG2576 transgenic mice
- Published in:
- 2006
- By:
- Publication type:
- Abstract
10
P4-268: Pharmacokinetics and pharmacodynamics of CHF5022 and CHF5074, two new β-amyloid<sub>1-42</sub> lowering agents, after multiple doses in TG2576 transgenic mice
- Published in:
- 2006
- By:
- Publication type:
- Abstract
11
Using illusions to understand hallucinations: differences in perceptual performances on illusory figures may underscore specific visuoperceptual impairments in Parkinson's disease.
- Published in:
- Frontiers in Neuroscience, 2023, p. 1, doi. 10.3389/fnins.2023.1256224
- By:
- Publication type:
- Article